← FDA Drug Approvals (Drugs@FDA)

NAPROXEN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA · Approved 2011-11-08

Drug application

FDA Application #
ANDA200429
Application type
Abbreviated New Drug Application (Generic)
Brand name
NAPROXEN
Generic name
NAPROXEN
Active ingredients
NAPROXEN
Dosage form
TABLET
Route
ORAL
Marketing status
Prescription
Sponsor
AUROBINDO PHARMA
Manufacturer
Aurobindo Pharma Limited
First approval
2011-11-08

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown